ANZCTR search results

These search results are from the Australian New Zealand Clinical Trials Registry (ANZCTR).

You can narrow down the results using the filters

34128 results sorted by trial registration date.
  • Effect of ADVice Versus exercISE via telehealth on shoulder pain and disability in adults with rotator cuff tendinopathy: a randomised controlled trial (the ADVISE trial)

    Rotator cuff tendinopathy is a common type of shoulder pain that can severely impact work and general function. It is not currently known whether exercise and education which is recommended care can be delivered via telehealth for this condition. Telehealth has huge advantages including convenience for the patient, ability to reach people in remote regions, and potential healthcare cost savings. The aim of this trial is to compare active control (online education leaflet only ARM 1) with exercise and education delivered via one session (ARM 2) or six sessions (ARM 3). We hypothesis that pain and function outcome will be superior in ARM 2 and 3 versus ARM 1 at 12 weeks. The primary outcome measure will be the Shoulder Pain and Disability Index (SPADI) at 3 months (enough to see an effect of the intervention on clinical outcomes) post randomization, a well validated, reliable and region-specific measure of shoulder pain and disability. This parallel group three-arm trial will randomise 333 people into the three trials arms. The education and exercise in arms 2 and 3 will be delivered via telehealth (Zoom) and in groups (3 participants to 1 physiotherapist). In Arm 3 follow up will occur at week 2, 4, 6, 9 and 12. Outcomes including pain, function, psychological status, sleep, quality of life, global rating of change, worse pain over the last 7-days, working alliance, adherence, health care use, exercise adherence, productivity, adverse events, and telehealth acceptability will be assessed at baseline, 6 weeks and 3 and 12 months.

  • Transforming treatments for schizophrenia: Virtual reality, brain stimulation and social cognition.

    Theory of mind is a social cognitive domain impaired in people with schizophrenia and has significant impact on functioning including difficulty in social interactions, poor interpersonal relationships and reduced conflict resolution ability. Current interventions are highly intensive, require significant resources and have only modest effects on functional outcomes and new innovative treatments are needed. Virtual reality (VR) and transcranial alternating current stimulation (tACS) will be combined to engage the rTPJ while undergoing theory of mind tasks and use electrical currents to further engage and enhance abnormal neural firing patterns simultaneously. Forty-six participants (23 schizophrenia, 23 controls) will attend 3 research sessions. One comprehensive baseline assessment completing a short interview and cognitive and social cognitive tasks as well as two VR social cognition tasks with simultaneous tACS. At the end of session three participants will have received one sham tACS and one active tACS session simultaneously with VR. We are investigating the effects of combining tACS with VR in single sessions on brain activity to inform future research and potential treatment. Participants will also complete short questionnaires regarding their experience.

  • CONFIRM: The Diagnostic Utility of Prostate Specific Membrane Antigen Positron Emission Tomography/Computed tomography (PSMA PET/CT) in Men with Newly Diagnosed Low-Grade Prostate Cancer with High-Risk Features, on Active Surveillance (regular testing for any changes in the cancer that could lead to harm), Awaiting Confirmatory Biopsy

    Who is it for? You may be eligible to join this study if you are aged 18 years or above, male, and have a new diagnosis of prostate cancer that is being managed through active surveillance. Study details All participants in this study will undergo the usual monitoring processes of mpMRI and confirmatory biopsy. In addition, all participants will undergo one PSMA PET scan at the time of their repeat mpMRI, and, if applicable, one PSMA-targeted biopsy at time of their confirmatory biopsy. The repeat mpMRI and PSMA PET/CT will occur at Epworth Medical Imaging, Freemasons. The results of the scans and biopsies will be used by a panel of experts to make recommendations as to whether the participant should remain on active surveillance for their prostate cancer, or receive active treatment. It is hoped that this research will improve the accuracy of prostate cancer monitoring, and lead to better outcomes for patients who are in active surveillance.

  • Gastroparesis symptoms and its treatment using low-viscosity soluble dietary fibres

    The principal aim of this clinical study was to determine the short-term blood-glucose control and tolerability of Partially-hydrolysed guar gum (PHGG) and Gum Arabic in mild-to-moderate symptom gastroparesis patients. There were four interventions in total, the test fibres PHGG and Gum Arabic, the positive control Psyllium Husk and the negative control Water. The study hypothesizes that the 'low-viscosity' test fibres PHGG and Gum Arabic provide blood glucose regulation / control comparable to the positive control, Psyllium Husk, while causing fewer severe symptoms comparable to the negative control, Water.

  • Seaweed extract, Fucoidan, as a supplement to support the development of muscle strength and function in sedentary individuals

    Edible seaweeds (macroalgae) have the potential to provide a rich and sustainable source of macronutrients and micronutrients to the human diet. The recent surge of interest in seaweed is fueled by attention on the bioactive components of seaweed, which have potential applications in the food and nutraceutical industries, with impetus toward the reducing cholesterol and improving blood sugar levels. One candidate bioactive compound of interest is the polysaccharide, Fucoidan. Fucoidans are found in brown seaweeds and the health benefits of Fucoidans have been demonstrated in both human and animal studies where the multiple effects include anti-inflammatory, anti-oxidant, anti-tumour, and immune-modulating properties. Our research group in collaboration with industry leading Fucoidan producers (Marinova Pty Ltd) have shown in a pre-clinical study in mice that in the absence of exercise, a novel Fucoidan blend increased muscle mass. While the animal study evidence does exist for Fucoidan influencing muscle health, more human evidence (including mechanistic evidence) is needed to evaluate both the nutritional benefit conferred and the efficacy of Fucoidan on muscle health. Therefore, the aim of this pilot clinical trial is to evaluate the effect of oral supplementation of a Fucoidan blend on muscle health and lean body mass in healthy human subjects not participating in any form of exercise. We hypothesize that fucoidan could be a supplement that increases muscle strength without a need for exercise. Here we propose a study designed to establish whether a novel fucoidan blend can improve muscle and body health in sedentary participants.

  • Safety of anticoagulation in elective colonoscopy

    The aim of this study is to investigate if patients can safely continue their blood thinner medication for small polypectomies without any procedure related complications.

  • EndoSMS: A text message supportive program for individuals with endometriosis

    With 1 in 9 Australians of childbearing age living with endometriosis, this chronic condition is characterised by debilitating physical symptoms which negatively impact on their psychological wellbeing and quality of life. This pilot study will assess the feasibility of a co-designed supportive text message program (EndoSMS) to enhance the psychological wellbeing and quality of life of those with endometriosis. Co-designed text message interventions have been demonstrated to improve health-promoting behaviours and medication adherence in individuals with chronic conditions and are a cost-efficient means of providing health education and support. Text messaging is particularly suited for young to middle-aged people (the majority of those impacted by endometriosis) because mobile phone ownership is high, little effort is required to receive the intervention, and texts can be read/re-read at times that suit users. Informed by psychological and communication theory, this study aims to develop a co-designed bank of text messages focused on providing evidence-based information about endometriosis management, psychological support and tips for self-care and a healthy lifestyle. Following co-designed development of the text message bank, piloting of the EndoSMS intervention will be undertaken with a minimum sample of 120 individuals living with endometriosis.

  • Comparison of tooth decay development around braces bonded to the tooth with two different adhesive materials.

    This within-patient, split-mouth randomised controlled trial aims to determine whether orthodontic bracket bonding with resin-modified glass ionomer cement (RMGIC) to sodium hypochlorite (NaOCl) conditioned enamel will affect the development of white spot lesions (WLSs) compared to brackets bonded with resin composite cement (RC). It is hypothesised that bonding with RMGIC after pre-treatment with NaOCl will reduce the prevalence of WSLs around orthodontic brackets compared to RC.

  • Vaccine choices, regret and patient characteristics in covid-19 positive patients admitted as an inpatient: a prospective multicentre trial

    Patient presents/referred to hospital, unvaccinated/vaccinated status is flagged SARS covid-19 infection is confirmed using standardised testing Patient is admitted as an inpatient in the RAH/FMC Approached for inclusion and participation by Dr Lin, on day 3 or whenever well enough. Inclusion and survey are completed either electronically or via a telephone system built into isolation bay. No face-to-face contact, no prolongation of in-person contact. No use of PPE or risk of additional exposure to staff. Microsoft Forms platform survey allowing for electronic signature for written informed consent, or if no electronic device available/other technical difficulty- patient gives verbal consent for the study investigator to electronically sign on their behalf. Survey is completed in same manner; electronic or via handset system built into isolation bay. Survey is conducted during inpatient admission on day 2 or whenever the patient can communicate adequately and is medically stable enough to complete a research survey. Study investigators will review patient for suitability from Day 2 of admission, on a daily basis. No long term follow-up. One time point for data collection.

  • The sensitivity and specificity of Gram stain on formalin fixed tissue sections in the diagnosis of bacterial skin infection - a study of diagnostic test accuracy

    This study aims to determine the test performance and diagnostic accuracy of Gram stain on FFPE tissue sections in diagnosing bacterial skin infection. Measures of test performance and diagnostic accuracy include sensitivity (the “true positive rate” or the ability of a test to identify positive cases correctly), specificity (the “true negative rate” or the ability of a test to identify negative cases correctly), positive predictive value (the probability of having a particular disease given a positive test result), negative predictive value (the probability of not have a particular disease given a negative test result), positive likelihood ratio (LR(+)) (the degree to which a person’s probability of having a particular disease is increased by having a positive test result), and negative likelihood ratio (LR(-)) (the degree to which a person’s probability of having a particular disease is decreased by having a negative test result). Although each of these parameters will be reported, our hypothesis focuses on test performance in terms of likelihood ratios, because likelihood ratios a more patient specific and therefore clinically appropriate measure of test performance. Our hypothesis is that Gram stain on FFPE tissue sections has poor test performance in diagnosing bacterial skin infection, as defined by LR(+) of less than 2 and LR(-) of more than 0.5. These thresholds for acceptable test performance are consistent with those reported by Schecter and Sheps (1985). If our hypothesis is confirmed, the findings of this study may encourage a more informed approach to test selection, improvements in healthcare resource utilisation, and enhance the interpretation of histopathology reports.

Tags:
  • Finding clinical trials